Nanobiotix S.A.

NBTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$34.50

+$1.45 (+4.39%)

At close: Sep 21, 2026, 4:00 PM ET

$34.15

-$0.35 (-1.02%)

Pre-market: Sep 22, 2026, 5:51 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.67B

Enterprise Value $1.53B

Beta 0.57

Average Volume 116.05K

Shares Outstanding (Diluted) 47.82M

Shares Change YoY 23.19%

Institutional Ownership 11.92%

Exchange NASDAQ

ISIN US63009J1079

Price Performance

Price Change 1M -15.3%

Price Change 3M -5.7%

Price Change 6M 12.6%

Price Change YTD 55.9%

Price Change 1Y 168.3%

Price Change 3Y 307.3%

Price Change 5Y 191.6%

1M CAGR (ann.) -12.5%

1Y CAGR (ann.) 224.0%

5Y CAGR (ann.) 22.1%

All-Time CAGR 12.2%

Valuation

PE Ratio -60.86

Forward PE 185.27

PEG Ratio -0.65

Forward PEG -5.22

PS Ratio 51.94

Forward PS 27.40

PB Ratio -17.59

P/FCF Ratio -45.33

P/Adj. FCF Ratio -41.05

P/OCF Ratio -43.47

EV/Sales 51.57

EV/EBIT -112.71

EV/EBITDA -126.68

EV/FCF -45.00

Earnings Yield -1.7%

FCF Yield -2.2%

Adj. FCF Yield -2.5%

Financial Health

Net Debt €39.47M

Total Debt €95.32M

Cash & Short-Term Investments €52.75M

Total Assets €67.76M

Current Ratio 1.09

Quick Ratio 1.09

Debt / Equity Ratio -1.13

Debt / EBITDA -7.90

Debt / FCF -2.81

OCF / Debt -0.35

Interest Coverage -1.04

Altman Z-Score 4.99

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 100.0%

Operating Profit Margin -36.5%

EBITDA Margin -40.7%

Net Profit Margin -80.8%

FCF Margin -114.6%

Adj. FCF Margin -126.5%

SBC / Revenue 11.9%

SBC Impact (per share) -10.4%

Returns

Return on Assets -35.4%

Return on Equity 31.2%

Return on Invested Capital -74.3%

Return on Capital Employed -105.5%

Return on Tangible Assets -35.4%

Historical Growth (CAGR)

Revenue CAGR 3Y 658.2%

Revenue CAGR 5Y 49.2%

Revenue CAGR 10Y 60.2%

EPS CAGR 3Y 43.4%

EPS CAGR 5Y 23.8%

EPS CAGR 10Y 5.6%

FCF CAGR 3Y -5.2%

FCF CAGR 5Y 2.3%

FCF CAGR 10Y -0.9%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y -22.0%

Revenue Growth Next 3Y -34.2%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $38

Price Target Upside 10.1%

Cash Flow

Operating Cash Flow €-33.42M

Free Cash Flow €-33.97M

Adj. Free Cash Flow €-37.51M

FCF Per Share -$0.72

OCF Per Share -$0.70

OCF/S Ratio -112.7%

Income Statement

Revenue €29.64M

Gross Profit €29.64M

Operating Income €-10.82M

EBITDA €-12.07M

Net Income €-23.96M

EPS (Diluted) -$0.50

Revenue / Employee $305.6K

Profit / Employee $-247.02K

Employees 97